Regenerative Medicine &
Gene Therapy Business
Nation-wide Expansion of Storage and
Transportation Facilities for Regenerative Medicine Products
Introduced “Regenerative Medicine Product Storage,” an ultra-low-temperature
storage and transport facility for regenerative medicine products
Regenerative medicine products require a stricter management system than ordinary pharmaceutical products, such as maintaining an ultra-low-temperature environment and ensuring traceability of each product.
The Alfresa Group has established “Regenerative Medicine Product Storage” equipped with storage tanks using liquid nitrogen at -150℃, ultra-low temperature freezers at -80℃, and systems for warehousing and inventory management at 12 distribution centers nationwide. We are strengthening our system for safe and secure storage and transportation.
The Alfresa Group has established “Regenerative Medicine Product Storage” equipped with storage tanks using liquid nitrogen at -150℃, ultra-low temperature freezers at -80℃, and systems for warehousing and inventory management at 12 distribution centers nationwide. We are strengthening our system for safe and secure storage and transportation.
We provide an ultra-low temperature (-150℃ or lower) storage and transportation environment with facilities using liquid nitrogen and other equipment to tailor to customer needs for storage and transport operations.
Regenerative Medicine Distribution Station
Regenerative Medicine Distribution Station locations have been established in
Kawasaki City, Kanagawa Prefecture and Kobe City, Hyogo Prefecture within
Mitsubishi Warehouse Co.
Regenerative Medicine Distribution Stations provide a storage and transport environment similar to that of a regenerative medicine warehouse, and can be used by pharmaceutical companies as a manufacturing (packaging, labeling, storage) or sales hub for regenerative medicine products, as well as a storage and transportation base for products used for clinical trials.
Deliveries for Clinical Trials
of Regenerative Medicine
Products
We act as a contact point to prepare transport materials in various temperature zones and make arrangements with transport and warehousing companies to develop an optimal nationwide delivery system.
Enabling optimal transport according to product characteristics from the clinical trial phase facilitates smooth distribution after the product is launched. Real-time temperature and location management are provided, with support for transport validation also available.
We will contribute to patients and medical institutions by providing safe and reliable distribution services to medical institutions in need of this system.
We will contribute to patients and medical institutions by providing safe and reliable distribution services to medical institutions in need of this system.
Integrated Value Chain Management
Platform for Regenerative Medicine Products
Japan’s first platform for integrated management of cell and tracing information for the entire value chain of regenerative medicine products, developed by Hitachi, Ltd. through collaboration with companies including Alfresa.
Our goal is to create a common service infrastructure for regenerative medicine products.
Our goal is to create a common service infrastructure for regenerative medicine products.
